PURPOSE: To develop a digital method for counting colonies that highly replicates manual counting. MATERIALS AND METHODS: Breast cancer cells were treated with trastuzumab-conjugated gold nanoparticles in combination with X-ray irradiation, (111)In labeled trastuzumab, or γ-radiation, followed by clonogenic assays. Colonies were counted manually or digitally using ImageJ software with customized macros. Key parameters, intensity threshold and minimum colony size, were optimized based on three preliminary manual counts or blindly chosen. The correlation of digital and manual counting and inter- and intra-experimenter variability were examined by linear regression. Survival curves derived from digital and manual counts were compared by F-test (P < 0.05). RESULTS: Using optimized parameters, digital counts corresponded linearly to manual counts with slope (S) and R(2) value close to 1 and a small y-intercept (y(0)): SK-BR-3 (S = 0.96 ± 0.02, R(2) = 0.969, y(0) = 5.9 ± 2.2), MCF-7/HER2-18 (S = 0.98 ± 0.03, R(2) = 0.952, y(0) = 0.74 ± 0.47), and MDA-MB-231 cells (S = 1.00 ± 0.02, R(2) = 0.995, y(0) = 3.3 ± 4.5). Both reproducibility and repeatability of digital counts were better than the manual method. Survival curves generated from digital and manual counts were not significantly different; P-values were 0.3646 for SK-BR-3 cells and 0.1818 for MCF-7/HER2-18 cells. Using blind parameters, survival curves generated by both methods showed some differences: P-values were 0.0897 for SK-BR-3 cells and 0.0024 for MCF-7/HER2-18 cells. CONCLUSIONS: The colony counting using ImageJ and customized macros with optimized parameters was a reliable method for quantifying the number of colonies.
PURPOSE: To develop a digital method for counting colonies that highly replicates manual counting. MATERIALS AND METHODS:Breast cancer cells were treated with trastuzumab-conjugated gold nanoparticles in combination with X-ray irradiation, (111)In labeled trastuzumab, or γ-radiation, followed by clonogenic assays. Colonies were counted manually or digitally using ImageJ software with customized macros. Key parameters, intensity threshold and minimum colony size, were optimized based on three preliminary manual counts or blindly chosen. The correlation of digital and manual counting and inter- and intra-experimenter variability were examined by linear regression. Survival curves derived from digital and manual counts were compared by F-test (P < 0.05). RESULTS: Using optimized parameters, digital counts corresponded linearly to manual counts with slope (S) and R(2) value close to 1 and a small y-intercept (y(0)): SK-BR-3 (S = 0.96 ± 0.02, R(2) = 0.969, y(0) = 5.9 ± 2.2), MCF-7/HER2-18 (S = 0.98 ± 0.03, R(2) = 0.952, y(0) = 0.74 ± 0.47), and MDA-MB-231 cells (S = 1.00 ± 0.02, R(2) = 0.995, y(0) = 3.3 ± 4.5). Both reproducibility and repeatability of digital counts were better than the manual method. Survival curves generated from digital and manual counts were not significantly different; P-values were 0.3646 for SK-BR-3 cells and 0.1818 for MCF-7/HER2-18 cells. Using blind parameters, survival curves generated by both methods showed some differences: P-values were 0.0897 for SK-BR-3 cells and 0.0024 for MCF-7/HER2-18 cells. CONCLUSIONS: The colony counting using ImageJ and customized macros with optimized parameters was a reliable method for quantifying the number of colonies.
Authors: Zhongli Cai; Simmyung Yook; Yijie Lu; Dane Bergstrom; Mitchell A Winnik; Jean-Philippe Pignol; Raymond M Reilly Journal: Pharm Res Date: 2016-12-16 Impact factor: 4.200
Authors: Ashley L Hein; Parthasarathy Seshacharyulu; Satyanarayana Rachagani; Yuri M Sheinin; Michel M Ouellette; Moorthy P Ponnusamy; Marc C Mumby; Surinder K Batra; Ying Yan Journal: Cancer Res Date: 2016-02-18 Impact factor: 12.701
Authors: Fernanda Musa; Amandine Alard; Gizelka David-West; John P Curtin; Stephanie V Blank; Robert J Schneider Journal: Mol Cancer Ther Date: 2016-05-16 Impact factor: 6.261
Authors: Brian D Yard; Priyanka Gopal; Kristina Bannik; Gerhard Siemeister; Urs B Hagemann; Mohamed E Abazeed Journal: Cancer Res Date: 2019-08-06 Impact factor: 12.701